1 PANTOPRAZOLE SODIUM | 400 of 2090 | 2990 prescriptions Less than 1% of all prescriptions | 2210 | 950 patients 17% of all patients | 740 patients 13% of all patients | |
2 OMEPRAZOLE | 210 of 2150 | 3360 prescriptions Less than 1% of all prescriptions | 2110 | 950 patients 17% of all patients | 620 patients 11% of all patients | |
3 RANITIDINE HCL | 240 of 1370 | 1110 prescriptions Less than 1% of all prescriptions | 870 | 320 patients 6% of all patients | < 11 | |
4 COLESTIPOL HCL | 20 of 250 | 840 prescriptions Less than 1% of all prescriptions | 710 | 210 patients 4% of all patients | < 11 | |
5 LINZESS (LINACLOTIDE) | 140 of 1370 | 710 prescriptions Less than 1% of all prescriptions | 560 | 210 patients 4% of all patients | < 11 | |
6 SUCRALFATE | 110 of 970 | 850 prescriptions Less than 1% of all prescriptions | 530 | 320 patients 6% of all patients | 200 patients 4% of all patients | |
7 DEXILANT (DEXLANSOPRAZOLE) | 130 of 990 | 580 prescriptions Less than 1% of all prescriptions | 250 | 170 patients 3% of all patients | < 11 | |
8 AMITIZA (LUBIPROSTONE) | 100 of 700 | 410 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
9 ESOMEPRAZOLE MAGNESIUM | 300 of 930 | 210 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
10 BUDESONIDE EC (BUDESONIDE) | 250 of 1050 | 260 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
11 URSODIOL | 290 of 730 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
12 APRISO (MESALAMINE) | 210 of 540 | 210 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
13 POLYETHYLENE GLYCOL 3350 | 350 of 640 | 200 prescriptions Less than 1% of all prescriptions | | 120 patients 2% of all patients | < 11 | |
14 MESALAMINE | 200 of 860 | 200 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
15 MERCAPTOPURINE | 100 of 290 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 DICYCLOMINE HCL | 360 of 1230 | 460 prescriptions Less than 1% of all prescriptions | 340 | 240 patients 4% of all patients | < 11 | |
17 AMITRIPTYLINE HCL | 120 of 230 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 FUROSEMIDE | 180 of 520 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 XIFAXAN (RIFAXIMIN) | 150 of 540 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |
20 PREDNISONE | 160 of 480 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 LACTULOSE | 180 of 580 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 PROPRANOLOL HCL | 70 of 210 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
23 VEMLIDY (TENOFOVIR ALAFENAMIDE) | 40 of 70 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
24 DIPHENOXYLATE-ATROPINE (DIPHENOXYLATE HCL/ATROPINE) | 290 of 690 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
25 CIMZIA (CERTOLIZUMAB PEGOL) | 20 of 50 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
26 GAVILYTE-G (PEG3350/SOD SULF,BICARB,CL/KCL) | 60 of 880 | 1150 prescriptions Less than 1% of all prescriptions | 970 | 1150 patients 21% of all patients | 970 patients 17% of all patients | |
27 ONDANSETRON ODT (ONDANSETRON) | 190 of 470 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
28 GAVILYTE-C (PEG3350/SOD SULF,BICARB,CL/KCL) | 100 of 280 | 410 prescriptions Less than 1% of all prescriptions | | 410 patients 7% of all patients | < 11 | |
29 PEG 3350-ELECTROLYTE (PEG3350/SOD SULF,BICARB,CL/KCL) | 110 of 460 | 420 prescriptions Less than 1% of all prescriptions | | 420 patients 8% of all patients | < 11 | |
30 PEG 3350-ELECTROLYTE (SODIUM CHLORIDE/NAHCO3/KCL/PEG) | 340 of 670 | 310 prescriptions Less than 1% of all prescriptions | | 310 patients 6% of all patients | < 11 | |
31 PEG-3350 AND ELECTROLYTES (PEG3350/SOD SULF,BICARB,CL/KCL) | 40 of 240 | 240 prescriptions Less than 1% of all prescriptions | | 240 patients 4% of all patients | < 11 | |